Key facts
- It has raised $31.5M; the latest was Early Stage VC in Sep 2024.
- Notable investors include Lux Capital, Union Square Ventures, Farvatn Venture, IA Ventures, Springbank Collective — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Alife
- ·The full record, as it builds
Funding rounds
No funding rounds for Alife are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Alife
Developer of an AI-based health technology designed to help people have healthy children. The company uses advancements in deep learning and software development technologies to help doctors select the healthiest embryos, enabling patients and future parents to improve their chances of a healthy pregnancy.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2020
- Employees
- 44
- Website
- alifehealth.com/
- Ownership
- Privately Held (backing)
Alife doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Alife shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Alife in its N-PORT filings yet. We sweep new filings monthly.